Attainment of combined optimal lipid values with the use of niacin: has AIM-HIGH closed the book on this debate?

Autor:	Tyan Thomas
Rok vydání:	2012
Předmět:	medicine.medical_specialty Atherogenic dyslipidemia business.industry Endocrinology Diabetes and Metabolism Pharmacology Clinical Practice Clinical question medicine In patient Statin therapy Cardiology and Cardiovascular Medicine Intensive care medicine business Niacin
Zdroj:	Clinical Lipidology. 7:389-396
ISSN:	1758-4302 1758-4299
DOI:	10.2217/clp.12.35
Popis:	The AIM-HIGH study results have provided new information for the clinical question regarding the potential benefit of the attainment of optimal lipid values to reduce residual cardiovascular risk in patients on optimal statin therapy. At first glance, it would seem that the early termination of this study owing to the perceived clinical futility of niacin therapy has effectively closed the debate on this topic. However, it is imperative that the clinician probes deeper into the study design and results before coming to this conclusion. This report will review the AIM-HIGH results and the impact on the clinical practice of adding niacin to optimized statin therapy in order to reduce residual cardiovascular risk.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::db56595997075b4b104b11a051f6fa0f https://doi.org/10.2217/clp.12.35 Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.